IL115617A - Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases - Google Patents

Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases

Info

Publication number
IL115617A
IL115617A IL11561795A IL11561795A IL115617A IL 115617 A IL115617 A IL 115617A IL 11561795 A IL11561795 A IL 11561795A IL 11561795 A IL11561795 A IL 11561795A IL 115617 A IL115617 A IL 115617A
Authority
IL
Israel
Prior art keywords
branched
linear
allergic diseases
type
prophylaxis
Prior art date
Application number
IL11561795A
Other languages
English (en)
Other versions
IL115617A0 (en
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of IL115617A0 publication Critical patent/IL115617A0/xx
Publication of IL115617A publication Critical patent/IL115617A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL11561795A 1994-10-17 1995-10-13 Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases IL115617A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25029394 1994-10-17

Publications (2)

Publication Number Publication Date
IL115617A0 IL115617A0 (en) 1996-01-19
IL115617A true IL115617A (en) 1999-11-30

Family

ID=17205757

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11561795A IL115617A (en) 1994-10-17 1995-10-13 Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases

Country Status (19)

Country Link
US (1) US5814649A (ko)
EP (1) EP0787491B1 (ko)
KR (1) KR100365064B1 (ko)
AT (1) ATE194912T1 (ko)
AU (1) AU695907B2 (ko)
CA (1) CA2202904C (ko)
DE (1) DE69518159T2 (ko)
DK (1) DK0787491T3 (ko)
ES (1) ES2148561T3 (ko)
FI (1) FI971584A (ko)
GR (1) GR3034413T3 (ko)
HU (1) HU222888B1 (ko)
IL (1) IL115617A (ko)
NO (1) NO315928B1 (ko)
NZ (1) NZ293691A (ko)
PT (1) PT787491E (ko)
TW (1) TW429146B (ko)
WO (1) WO1996011682A1 (ko)
ZA (1) ZA958708B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150808T3 (es) * 1997-08-08 2000-12-01 Aventis Pharma Gmbh Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico.
BR9908105A (pt) 1998-02-19 2000-10-17 Kowa Co Composto de amida cìclica.
US6303652B1 (en) 1998-08-21 2001-10-16 Hughes Institute BTK inhibitors and methods for their identification and use
WO2002034251A1 (en) * 2000-10-20 2002-05-02 Parker Hughes Institute Treatment of asthma with lfm analogues
EP1244468A2 (en) * 2000-01-07 2002-10-02 University Of Cincinnati Selective activation of a th1 or th2 lymphocyte regulated immune response
US6849260B2 (en) 2000-08-18 2005-02-01 Amgen Inc. Methods and compositions for treating IgE-related disease using NNT-1 inhibitors
US6706703B2 (en) 2001-06-29 2004-03-16 Kowa Co., Ltd. Bis(5-aryl-2-pyridyl) derivatives
US6890940B2 (en) 2001-06-29 2005-05-10 Kowa Co., Ltd. Bis(2-aryl-5-pyridyl) derivatives
US8283515B2 (en) 2002-05-03 2012-10-09 Sca Hygiene Products Ab Absorbent article containing a skin conditioning agent
PE20121478A1 (es) 2009-09-18 2012-11-12 Sanofi Sa Formulaciones en comprimido de teriflunomida: "(4'-trifluorometilfenil) amida del acido (z)-2-ciano-3-hidroxibut-2-enoico con estabilidad mejorada

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
TW314467B (ko) * 1993-03-31 1997-09-01 Hoechst Ag

Also Published As

Publication number Publication date
DE69518159T2 (de) 2002-01-03
IL115617A0 (en) 1996-01-19
HUT77135A (hu) 1998-03-02
DK0787491T3 (da) 2000-10-16
EP0787491B1 (en) 2000-07-26
EP0787491A4 (en) 1998-09-30
FI971584A0 (fi) 1997-04-15
FI971584A (fi) 1997-04-15
AU3618695A (en) 1996-05-06
KR970706811A (ko) 1997-12-01
KR100365064B1 (ko) 2003-04-11
ES2148561T3 (es) 2000-10-16
GR3034413T3 (en) 2000-12-29
ATE194912T1 (de) 2000-08-15
DE69518159D1 (de) 2000-08-31
CA2202904A1 (en) 1996-04-25
ZA958708B (en) 1996-05-14
NO971743D0 (no) 1997-04-16
WO1996011682A1 (fr) 1996-04-25
HU222888B1 (hu) 2003-12-29
NZ293691A (en) 1999-07-29
EP0787491A1 (en) 1997-08-06
US5814649A (en) 1998-09-29
PT787491E (pt) 2000-11-30
NO971743L (no) 1997-04-16
NO315928B1 (no) 2003-11-17
TW429146B (en) 2001-04-11
CA2202904C (en) 2006-12-19
AU695907B2 (en) 1998-08-27

Similar Documents

Publication Publication Date Title
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
TW430660B (en) Novel benzindole derivatives for neuron cell protection, processes for production, and the pharmaceutical compounds containing them
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
GR3031917T3 (en) Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
AU695907B2 (en) Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE69315836D1 (de) Pyrazolpyridine für die behandlung der anämie
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
ATE352317T1 (de) Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE69614508D1 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
NO20004679L (no) Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse
ES2116528T3 (es) Nuevo compuesto, la leustroducsina h, su preparacion y su utilizacion terapeutica.
MX9604072A (es) Derivados de oxazolidinona y composiciones farmaceuticas que los contienen.
AU1925500A (en) 4&#39;-substituted-4&#39;,5&#39;-dihydropsoralens and therapeutical uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees